News Search Results
Sep 02, 2025, 08:00 ET Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)
Sept. 2, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced participation in two upcoming scientific
More news about: Kodiak Sciences Inc.
Sep 02, 2025, 08:00 ET EDETEK Launches BioStat.AI: The Industry's First Unified AI Platform for Clinical Data, Biostatistics, and Programming
solutions company that provides high-quality Artificial Intelligence-powered technology platforms and related clinical services to pharmaceutical, biotechnology, and medical device companies. With a global presence across four continents and serving clinical development globally, EDETEK's commitment to excellence
More news about: EDETEK, Inc.
Sep 02, 2025, 08:00 ET Melodia Therapeutics Appoints Jonathan Talbot as CEO, Sven Zimmermann as Chairman of the Board and Brings Renowned Scientific and Clinical Advisors to Propel Lead Program MLD-151 Towards the Clinic
Amsterdam in September 2025. About Melodia Therapeutics Melodia Therapeutics is a Swiss-based biotechnology company focused on developing oral therapies that target neutrophilic inflammation. Its lead candidate, MLD-151, is a novel DPP1 inhibitor designed
More news about: Melodia Therapeutics AG
Sep 02, 2025, 08:00 ET SystImmune, Inc. to Present New iza-bren (izalontamab brengitecan) Data in Non-Small Cell Lung Cancer at WCLC Congress 2025
Sept. 2, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that two abstracts for iza-bren (izalontamab brengitecan), a potentially first-in-class EGFRxHER3 bispecific antibody drug
More news about: SystImmune, Inc.
Sep 02, 2025, 08:00 ET ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives
DeFi founders, infrastructure pioneers and other ecosystem heavyweights. The Company, originally formed as an innovative biotechnology company, has also been evolving its business towards software enabled gaming and entertainment. In addition to its ETH treasury strategy
More news about: ETHZilla Corporation
Sep 02, 2025, 07:47 ET Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
Sept. 2, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system
More news about: Intensity Therapeutics Inc.
Sep 02, 2025, 07:30 ET Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Sep 02, 2025, 07:22 ET BPC Instruments expands into the textile sector - receives order from a global materials company
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Sep 02, 2025, 07:00 ET Nanoscope Strengthens Global Regulatory Pathways for MCO-010 with FDA RMAT and Five EMA Orphan Designations
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic therapies for patients with photoreceptor loss and vision impairment
More news about: Nanoscope Therapeutics
Sep 02, 2025, 06:38 ET Specialty Polymer Market Size to Project USD 179.48 Billion by 2035 | CAGR 6.75% | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 02, 2025, 06:00 ET Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
September 15 to 19, 2025. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Sep 02, 2025, 03:00 ET CS Analytical & Gas Testing Analytical Hosting Educational Webinar on USP/EP Gas Qualification Testing
requirements in an easily digestible manner so that attendees can feel confident about meeting their gas testing needs." In pharmaceutical, biotechnology, and medical device manufacturing, the quality and purity of process utilities are critical to ensuring product safety, efficacy, and regulatory
More news about: CS Analytical
Sep 02, 2025, 02:20 ET Global Cancer Diagnostics Market to Hit USD 215 Billion by 2035, Growing at 6.35% CAGR | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 01, 2025, 17:31 ET TLR7/8 Agonists Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight
LLC, Iovance Biotherapeutics, Inc., Novartis Pharmaceuticals, AstraZeneca, Exelixis, Transgene, Immunocore Ltd, BeiGene, Biocad, Shandong Boan Biotechnology Co., Ltd, Merck Sharp & Dohme LLC, Genentech, Inc., Aulos Bioscience, Inc., Multitude Therapeutics Inc., Amgen, among others.
More news about: DelveInsight Business Research, LLP
Sep 01, 2025, 10:01 ET Contract Logistics Market to Reach US$525.29 Billion By 2031, With CAGR Of 7.2% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 01, 2025, 10:01 ET Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™.
and infectious diseases worldwide, which has boosted the demand for early and accurate diagnostic solutions. Moreover, the rapid expansion of the biotechnology and biopharmaceutical sectors, along with rising investments in diagnostic research, significantly supports the widespread adoption of immunoassay
More news about: MarketsandMarkets
Sep 01, 2025, 09:00 ET Norma Completes Quantum AI Algorithm Validation on NVIDIA
the development and execution of quantum algorithms. Norma is independently developing quantum AI algorithms applicable across sectors such as biotechnology, defense, and finance. The company is currently running projects to execute these algorithms in the CUDA-Q environment and validate their performance.
More news about: Norma
Sep 01, 2025, 09:00 ET Norma Completes Quantum AI Algorithm Validation on NVIDIA
the development and execution of quantum algorithms. Norma is independently developing quantum AI algorithms applicable across sectors such as biotechnology, defense, and finance. The company is currently running projects to execute these algorithms in the CUDA-Q environment and validate their performance.
More news about: Norma
Aug 29, 2025, 18:15 ET PHARMARESEARCH schließt Partnerschaft mit Laboratoires VIVACY für den Vertrieb von „Rejuran" in Europa ab
weltweit erste injizierbare Produkt für die funktionelle und ästhetische Gynäkologie, bekannt. VIVACY ist kürzlich eine Partnerschaft mit Burgeon Biotechnology für den Biostimulator NOVUMA® eingegangen. VIVACY stellt seine Produkte in seinem Hightech-Werk in Archamps Technopole, Frankreich, her und ist
More news about: PharmaResearch
Aug 29, 2025, 18:11 ET PHARMARESEARCH établit un partenariat avec les Laboratoires VIVACY pour la distribution de « REJURAN » en Europe
DESIRIAL®, le premier produit injectable au monde pour la gynécologie fonctionnelle et esthétique. VIVACY a récemment conclu un partenariat avec Burgeon Biotechnology pour le biostimulateur NOVUMA®. Avec des produits fabriqués sur son site de haute technologie à Archamps Technopole, en France,
More news about: PharmaResearch
Aug 29, 2025, 16:01 ET AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 29, 2025, 10:44 ET Expert Panel to Discuss Innovations in Alzheimer's Disease Clinical Trials
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 29, 2025, 10:31 ET Gas Turbine Market is projected to reach US$ 32,005.2 million by 2031; it is expected to register a CAGR of 4.84% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 29, 2025, 10:15 ET Pharmaceutical Contract Manufacturing Market worth US$311.95 billion by 2030 with 8.2% CAGR | MarketsandMarkets™
medicines, biologics, consumer & animal health products, with sophisticated delivery methods. To satisfy the needs of the pharmaceutical and biotechnology sectors, the company presents several oral, injectable, and respiratory delivery systems. It also increased drug substance manufacturing capacity
More news about: MarketsandMarkets
Aug 29, 2025, 10:03 ET Centrifugal Pump Market projected to reach US$ 55.58 billion by 2031 at CAGR of 5.7% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners